Sandostatin (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Sandostatin drug offered from Novartis Pharmaceuticals Corporation. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | octreotide acetate |
| SUBSTANCE NAME: | OCTREOTIDE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1988-10-21 |
| END MARKETING DATE: | 0000-00-00 |
Sandostatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sandostatin from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(ug/mL) |
| START MARKETING DATE: | 1988-10-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0180_88515a7e-2535-4fac-918f-9321515f8320 |
| PRODUCT NDC: | 0078-0180 |
| APPLICATION NUMBER: | NDA019667 |
Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:
